PR Newswire - Innovent Presents Phase 1 Clinical Data of First-i...
SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerc...
Read More

ภาษาไทย
English